T

T&L Co Ltd
KOSDAQ:340570

Watchlist Manager
T&L Co Ltd
KOSDAQ:340570
Watchlist
Price: 64 400 KRW -0.92% Market Closed
Market Cap: 523.6B KRW
Have any thoughts about
T&L Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one T&L Co Ltd stock under the Base Case scenario is 107 477.36 KRW. Compared to the current market price of 64 400 KRW, T&L Co Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
107 477.36 KRW
Undervaluation 40%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

5.1
P/S
P/S
Price to Sales
5.1
vs History
14
vs Industry
27
Median 3Y
4.1
Median 5Y
4.1
Industry
2.3
Forward
2.9
More Details
19.8
P/E
P/E
Price to Earnings
19.8
vs History
12
vs Industry
30
Median 3Y
15.7
Median 5Y
15.7
Industry
23.1
Forward
10.4
More Details
17.1
P/OCF
P/OCF
Price to OCF
17.1
vs History
43
vs Industry
15
Median 3Y
17.5
Median 5Y
17.6
Industry
14.2
More Details
25.3
P/FCFE
P/FCFE
Price to FCFE
25.3
vs History
46
vs Industry
Median 3Y
24.8
Median 5Y
25.7
Industry
20.1
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
26
vs Industry
20
Median 3Y
3.4
Median 5Y
3.4
Industry
2.2
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
14
vs Industry
26
Median 3Y
3.8
Median 5Y
3.6
Industry
2.4
Forward
2.7
More Details
11.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.3
vs History
16
vs Industry
20
Median 3Y
8.9
Median 5Y
8.7
Industry
5
More Details
14.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.5
vs History
16
vs Industry
26
Median 3Y
11.3
Median 5Y
11.8
Industry
12.7
Forward
10
More Details
16.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.2
vs History
14
vs Industry
31
Median 3Y
12.2
Median 5Y
12.7
Industry
17.1
Forward
8.4
More Details
15.4
EV/OCF
EV/OCF
Enterprise Value to OCF
15.4
vs History
36
vs Industry
17
Median 3Y
15.8
Median 5Y
15.7
Industry
14
More Details
22.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.8
vs History
43
vs Industry
Median 3Y
22.3
Median 5Y
23.1
Industry
18
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
34
vs Industry
17
Median 3Y
4
Median 5Y
4.1
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
T&L Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
T&L Co Ltd
KOSDAQ:340570
519.8B KRW 5.1 19.8 14.5 16.2
JP
Hoya Corp
TSE:7741
6.8T JPY 8.6 35.8 23.7 28.7
CH
Alcon AG
SIX:ALC
37.6B CHF 4.3 36.3 17.8 34.5
DK
Coloplast A/S
CSE:COLO B
179.6B DKK 6.6 35.6 22.9 26.9
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD 4 35.7 18 21.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.4B CNY 11.6 27.8 24.1 24.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.4 -17.2 16.7 55.8
KR
HLB Inc
KOSDAQ:028300
9.1T KRW 175.4 -49 -75.4 -71.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD 4.1 14.5 10 11.3
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.2 264.5 462.1
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.7 23.8 39
P/E Multiple
Earnings Growth P/E to Growth
KR
T
T&L Co Ltd
KOSDAQ:340570
Average P/E: 32.2
19.8
140%
0.1
JP
Hoya Corp
TSE:7741
35.8
52%
0.7
CH
Alcon AG
SIX:ALC
36.3
107%
0.3
DK
Coloplast A/S
CSE:COLO B
35.6
50%
0.7
US
Align Technology Inc
NASDAQ:ALGN
35.7
102%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.8
92%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.2 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -49 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.5
69%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
37.2
208%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.7
159%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
T
T&L Co Ltd
KOSDAQ:340570
Average EV/EBITDA: 43.6
14.5
187%
0.1
JP
Hoya Corp
TSE:7741
23.7
51%
0.5
CH
Alcon AG
SIX:ALC
17.8
34%
0.5
DK
Coloplast A/S
CSE:COLO B
22.9
39%
0.6
US
Align Technology Inc
NASDAQ:ALGN
18
52%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
103%
0.2
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
82%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -75.4 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10
43%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
264.5
42%
6.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.8
81%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
T
T&L Co Ltd
KOSDAQ:340570
Average EV/EBIT: 72
16.2
196%
0.1
JP
Hoya Corp
TSE:7741
28.7
N/A N/A
CH
Alcon AG
SIX:ALC
34.5
107%
0.3
DK
Coloplast A/S
CSE:COLO B
26.9
42%
0.6
US
Align Technology Inc
NASDAQ:ALGN
21.7
58%
0.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
87%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
55.8
283%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.1 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.3
47%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
462.1
96%
4.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
39
148%
0.3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.